SELLAS Life Sciences Group, Inc.
(NASDAQ : SLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -3.05%240.161.3%$818.41m
MRNAModerna, Inc. -3.76%67.250.0%$734.66m
NVAXNovavax, Inc. 1.60%110.0996.5%$705.03m
IMMUImmunomedics, Inc. 0.02%85.5511.0%$601.11m
GILDGilead Sciences, Inc. -1.97%63.771.0%$587.35m
REGNRegeneron Pharmaceuticals, Inc. -1.19%548.662.7%$439.82m
VRTXVertex Pharmaceuticals, Inc. -1.44%261.571.9%$324.43m
BIIBBiogen, Inc. -2.83%266.721.6%$323.55m
ILMNIllumina, Inc. -6.23%277.083.5%$293.58m
SRNESorrento Therapeutics, Inc. -1.11%9.331.5%$271.90m
ALXNAlexion Pharmaceuticals, Inc. -2.47%110.912.0%$259.96m
MNTAMomenta Pharmaceuticals, Inc. 0.18%52.363.0%$237.79m
BMRNBioMarin Pharmaceutical, Inc. -2.61%77.314.3%$233.25m
VXRTVaxart, Inc. 6.57%8.760.0%$227.60m
SGENSeattle Genetics, Inc. -1.50%178.226.0%$191.23m

Company Profile

SELLAS Life Sciences Group, Inc. engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and ct-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.